Omnicef and Remeron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omnicef (cefdinir) and Remeron (mirtazapine). Common drug interactions include weight decreased among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Omnicef and Remeron. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Omnicef?

Omnicef has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 2,774 Omnicef users. Check the latest studies of Omnicef.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,474 Remeron users. Check the latest studies of Remeron.



On Jul, 14, 2026

12 people who take Omnicef and Remeron together, and have interactions are studied.

Omnicef and Remeron drug interactions.

What are the common drug interactions of Omnicef and Remeron, by gender? *:

female:

  1. Weight decreased
  2. Blood pressure increased
  3. Bone pain
  4. Cardiac failure congestive
  5. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  6. Headache (pain in head)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nausea (feeling of having an urge to vomit)
  9. Oedema peripheral (superficial swelling)
  10. Pulmonary hypertension (increase in blood pressure in the lung artery)

male:

  1. Chronic kidney disease
  2. Diarrhoea
  3. Drug hypersensitivity
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Periodic limb movement disorder
  6. Rash generalised (rash on most of body parts)
  7. Renal failure (kidney dysfunction)
  8. Spinal fracture (fracture in one of vertebrae)
  9. Therapeutic response unexpected

What are the common drug interactions of Omnicef and Remeron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Confusional state
  2. Fear
  3. Hallucination (an experience involving the perception of something not present)
  4. Migraine (headache)
  5. Muscle spasms (muscle contraction)
  6. Overdose
  7. Pancreatitis (inflammation of pancreas)
  8. Pancreatitis acute (sudden inflammation of pancreas)
  9. Self-induced vomiting
  10. Type 2 diabetes mellitus

30-39:

  1. Anxiety disorder
  2. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  3. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  4. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  5. Meningitis bacterial (bacterial inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  6. Otitis media (inflammation of the middle ear)
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Panic disorder
  9. Type 2 diabetes mellitus

40-49:

  1. Bone pain
  2. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  3. Diarrhoea
  4. Joint injury
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Memory impairment
  7. Nausea (feeling of having an urge to vomit)
  8. Tendon disorder (disease of tendon)
  9. Vomiting
  10. Weight decreased

50-59:

  1. Diabetic retinopathy (damage to the retina caused by complications of diabetes)
  2. Oedema peripheral (superficial swelling)
  3. Pulmonary hypertension (increase in blood pressure in the lung artery)
  4. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  5. Type 2 diabetes mellitus
  6. Blood pressure increased
  7. Cardiac failure congestive

60+:

  1. Chronic kidney disease
  2. Fall
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Headache (pain in head)
  5. Muscular weakness (muscle weakness)
  6. Renal failure (kidney dysfunction)
  7. Urinary tract infection
  8. Weight decreased

What are the existing conditions these people have? *

  1. Sleep Disorder: 5 people, 41.67%
  2. Bipolar Disorder (mood disorder): 2 people, 16.67%
  3. Pain: 2 people, 16.67%
  4. Stress And Anxiety: 1 person, 8.33%
  5. High Blood Pressure: 1 person, 8.33%
  6. Affective Disorder (mental disorder): 1 person, 8.33%
  7. Asthma: 1 person, 8.33%
  8. Breast Cancer: 1 person, 8.33%
  9. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 8.33%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Omnicef and Remeron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Omnicef and Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omnicef:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Remeron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omnicef and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remeron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and mirtazapine (the active ingredients of Omnicef and Remeron, respectively), and Omnicef and Remeron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: